Welcome to the repository of current of IJIBPQ. This section provides access to all published content, allowing readers to explore the latest advancements and archived contributions in the field of biopharmaceutical manufacturing and quality research.
Featured Articles in the Latest Issue
- Volume 2 (Issue 1) JANUARY- JUNE 2026
Research Articles
Process Intensification Strategies in Continuous Bioreactors for Improved Monoclonal Antibody Output
Vol.2(1); Pages:1-10. Published on March-2026
Abstract
The increasing demand for monoclonal antibodies has intensified the need for efficient and scalable biomanufacturing processes. This study explores the integration of artificial intelligence (AI)-driven control systems into bioreactor operations to enhance productivity and process stability. Using a fed-batch culture system, we implemented machine learning algorithms capable of real-time monitoring and adaptive parameter optimization, including pH, dissolved oxygen, and nutrient feed rates. Experimental validation demonstrated a 28% increase in antibody yield and a 15% reduction in process variability compared to conventional control methods. Furthermore, the AI model successfully predicted metabolic shifts, enabling pre-emptive adjustments that minimized cell stress and apoptosis. Data analysis confirmed improved glycosylation consistency, which is critical for therapeutic efficacy. The study highlights the transformative potential of AI in biopharmaceutical manufacturing, offering a scalable and cost-effective approach to meet global therapeutic demands. Future research should focus on regulatory integration and cross-platform adaptability of such intelligent systems.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Advanced Lyophilization Techniques for Stability Improvement of Protein Therapeutics
Vol.2(1); Pages:11-19. Published on March-2026
Abstract
Protein-based therapeutics are highly sensitive to environmental conditions, necessitating robust stabilization methods. This study evaluates advanced lyophilization techniques aimed at enhancing the long-term stability of protein drugs. Traditional freeze-drying protocols were compared with controlled nucleation and annealing based processes. Model proteins were subjected to various freezing rates and excipient formulations to assess structural integrity post-lyophilization. Analytical methods including differential scanning calorimetry and circular dichroism spectroscopy revealed that controlled nucleation significantly reduced heterogeneity in ice crystal formation, leading to improved preservation of protein conformation. Furthermore, optimized excipient combinations containing trehalose and glycine demonstrated superior protection against aggregation during storage. Stability studies conducted over three months indicated a marked reduction in degradation rates in samples processed with advanced techniques. The results underscore the importance of process control in lyophilization and provide a framework for developing stable, high-quality biopharmaceutical products suitable for global distribution.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Implementation of AI-Driven Quality Control in Biopharmaceutical Manufacturing
Vol.2(1); Pages:20-28. Published on April-2026
Abstract
Ensuring consistent product quality in biopharmaceutical manufacturing remains a critical challenge due to process variability and complex biological systems. This study investigates the integration of artificial intelligence (AI) tools into quality control workflows to enhance predictive accuracy and operational efficiency. Machine learning models were developed using historical production data to identify critical process parameters influencing product quality. The AI system was implemented in a pilot-scale manufacturing setup, enabling real-time anomaly detection and process adjustments. Results indicated a significant reduction in batch failures and deviations, with predictive models achieving over 90% accuracy in identifying potential quality issues. Additionally, the system facilitated faster decision-making and reduced reliance on manual inspections. The study demonstrates that AI-driven quality control can transform traditional manufacturing paradigms by enabling proactive management of production processes, ultimately improving compliance with regulatory standards and ensuring the delivery of safe and effective biopharmaceutical products.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Single-Use Technologies in Biopharma: Impact on Production Efficiency and Contamination Risk
Vol.2(1); Pages:29-38. Published on May-2026
Abstract
Single-use technologies (SUTs) have emerged as a transformative approach in biopharmaceutical manufacturing, offering flexibility and reduced contamination risks. This study assesses the operational impact of SUTs in comparison with traditional stainless-steel systems across multiple production facilities. Data were collected on parameters such as setup time, cleaning requirements, cross-contamination incidents, and production throughput. The findings revealed that SUTs significantly decreased turnaround time by eliminating cleaning validation steps and reduced contamination incidents by 40%. However, challenges related to material compatibility and waste management were also identified. Despite these limitations, the overall efficiency gains and reduced capital investment requirements make SUTs an attractive option for modern biopharma facilities. The study provides a comprehensive evaluation of SUT implementation, highlighting its role in enhancing manufacturing agility and supporting the rapid scale-up of biologics production in response to global healthcare demands.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Regulatory Compliance Strategies for Global Biopharmaceutical Supply Chains
Vol.2(1); Pages:39-47. Published on May-2026
Abstract
The globalization of biopharmaceutical supply chains introduces complex regulatory challenges that require harmonized compliance strategies. This review examines current regulatory frameworks across major markets, including North America, Europe, and Asia, focusing on quality standards, documentation requirements, and inspection protocols. Key challenges identified include discrepancies in regulatory expectations, delays in approval processes, and logistical barriers affecting product distribution. The study highlights the role of international guidelines such as ICH standards in promoting regulatory convergence and facilitating smoother market access. Case studies of multinational biopharma companies were analyzed to identify best practices in compliance management, including the adoption of centralized documentation systems and risk-based quality approaches. The findings emphasize the need for proactive regulatory planning and cross-border collaboration to ensure uninterrupted supply of critical biologics. This review contributes valuable insights for policymakers and industry stakeholders aiming to strengthen global biopharmaceutical supply chain resilience.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Accessing the Articles
You can access the full text of these articles by clicking on the titles or visiting our journal’s online archives.
Stay Updated
To stay informed about the latest research and updates in the journal, consider subscribing to our newsletter or following us on social media.
